Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled (Unreturned Annual)
Current status date:
2024-01-08
Original market date: See footnote 1
Product name:
VITAMIN D3 ORAL SOLUTION
DIN:
02512181
Product Monograph/Veterinary Labelling:
Date:
2021-02-05
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
GALEPHAR PHARMACEUTICAL RESEARCH INC
Carr 925 Km 6.1 Barrio Junquitos
Humacao
--
Puerto Rico
00792
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
88:16.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A11CC05 COLECALCIFEROL
Active ingredient group (AIG) number:See footnote5
0108524012
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| VITAMIN D3 | 25000 UNIT / AMP |